Karyopharm Therapeutics – I am paid less than others at the same level

Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory

Comparably Awards

Karyopharm Therapeutics Empresa reivindicada

Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions consulte Mais informação

Esta empresa está aceitando feedback de funcionários verificados FUNCIONÁRIO PARTICIPANTES: 90

TOTAL CLASSIFICAÇÕES: 2628

CEO: Richard Paulson

I am paid less than others at the same level

Other Employee Reviews for Karyopharm Therapeutics

Brevemente descreva a sua experiência na companhia.

One of the best career choices I have ever made

Brevemente descreva a sua experiência na companhia.

I have only been at the company for three months now. However in the 3 months I have worked on numerous projects across a variety of different departments. My current position (corporate communications) has allowed me to create and work with so many different employees with different backgrounds .

Brevemente descreva a sua experiência na companhia.

challenging, rewarding, exciting, collaborative, meaningful

Brevemente descreva a sua experiência na companhia.

I am challenged, I learn a lot, and I make a difference. These are the key pieces for me!

Brevemente descreva a sua experiência na companhia.

A very good place to experience a lot and move at a fast pace; however, often frustrating due to lack of focus on main objectives for the company.

×

Rate your company